Proceeds from exercise of stock
purchase warrants 5 1,042
------------- -----------
Net cash provided by
financing activities 5 10,095
Effect of exchange rate changes
on cash (2) (28)
------------- -----------
Net change in cash (10,926) 5,050
Cash and cash equivalents at
beginning of period 11,867 9,022
------------- -----------
Cash and cash equivalents at end
of period $ 941 $ 14,072
============= ===========
Supplemental disclosure of cash
flow information:
Cash paid during period for
interest $ 9 $ 9
============= ===========
Supplemental Disclosure of
non-cash transactions:
Fair value of common stock,
stock options and stock
warrants issued as
consideration for asset
acquisition $ 9,605 $ -
============= ===========
(END) Dow Jones Newswires
November 10, 2022 18:00 ET (23:00 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.